Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited.

Hyperinsulinemia and insulin resistance were proposed more than 30 years ago to be important contributors to elevated blood pressure (BP) associated with obesity and the metabolic syndrome, also called syndrome X. Support for this concept initially came from clinical and population studies showing correlations among hyperinsulinemia, insulin resistance, and elevated BP in individuals with metabolic syndrome. Short-term studies in experimental animals and in humans provided additional evidence that hyperinsulinemia may evoke increases in sympathetic nervous system (SNS) activity and renal sodium retention that, if sustained, could increase BP. Although insulin infusions may increase SNS activity and modestly raise BP in rodents, chronic insulin administration does not significantly increase BP in lean or obese insulin-resistant rabbits, dogs, horses, or humans. Multiple studies in humans and experimental animals have also shown that severe insulin resistance and hyperinsulinemia may occur in the absence of elevated BP. These observations question whether insulin resistance and hyperinsulinemia are major factors linking obesity/metabolic syndrome with hypertension. Other mechanisms, such as physical compression of the kidneys, activation of the renin-angiotensin-aldosterone system, hyperleptinemia, stimulation of the brain melanocortin system, and SNS activation, appear to play a more critical role in initiating hypertension in obese subjects with metabolic syndrome. However, the metabolic effects of insulin resistance, including hyperglycemia and dyslipidemia, appear to interact synergistically with increased BP to cause vascular and kidney injury that can exacerbate the hypertension and associated injury to the kidneys and cardiovascular system.

• Publication year

  2020

• Venue

  Canadian Journal of Cardiology

• Publication date

  2020-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.cjca.2020.02.066PMID 32389340PMCID PMC7219403
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effect of insulin infusion on heart rate and systemic blood pressure in horses with equine metabolic syndrome.

  2019cited by this paper
• The melanocortin pathway and control of appetite-progress and therapeutic implications.

  2019cited by this paper
• Continuous Subcutaneous Insulin Infusion Initiation Is Associated With Blood Pressure Reduction in Adults With Type 1 Diabetes

  2019cited by this paper
• Sex differences in the sympathoexcitatory response to insulin in obese rats: role of neuropeptide Y

  2019cited by this paper
• The integrative biology of type 2 diabetes

  2019cited by this paper
• Melanocortin-4 Receptor Signalling: Importance for Weight Regulation and Obesity Treatment.

  2019cited by this paper
• Impact of leptin deficiency compared to neuronal specific leptin receptor deletion on cardiometabolic regulation.

  2019cited by this paper
• Leptin and Aldosterone.

  2019cited by this paper
• Melanocortin-4 Receptors and Sympathetic Nervous System Activation in Hypertension

  2019cited by this paper
• Obesity, kidney dysfunction and hypertension: mechanistic links

  2019cited by this paper
• Device-Based Neuromodulation for Resistant Hypertension Therapy: Too Early for Prime Time?

  2019cited by this paper
• Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies

  2018cited by this paper
• International Association for the Study of Obesity

  2018cited by this paper
• Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management.

  2018cited by this paper
• Associations of dipping and non-dipping hypertension with cardiovascular diseases in patients with dyslipidemia

  2018cited by this paper
• Mechanisms of Insulin Action and Insulin Resistance.

  2018cited by this paper
• Natriuretic Peptides in Cardiovascular and Metabolic Crosstalk: Implications for Hypertension Management.

  2018cited by this paper
• Sleep Apnea and Cardiovascular Disease: An Enigmatic Risk Factor.

  2018cited by this paper
• The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease

  2018cited by this paper
• Acute effects of insulin on circulating natriuretic peptide levels in humans

  2018cited by this paper
• Sex Differences in Mechanisms of Hypertension Associated With Obesity

  2018cited by this paper
• Obesity Paradox in Hypertension: Is This Because Sympathetic Activation in Obesity-Hypertension Takes a Benign Form?

  2018cited by this paper
• Chronic renal artery insulin infusion increases mean arterial pressure in male Sprague-Dawley rats.

  2018cited by this paper
• Erratum to: Blood pressure response to catheter-based renal sympathetic denervation in severe resistant hypertension: data from the Greek Renal Denervation Registry

  2017cited by this paper
• Use of Aldosterone Antagonists for Treatment of Uncontrolled Resistant Hypertension

  2017cited by this paper
• Apparent mineralocorticoid excess.

  2017cited by this paper
• Blood pressure in Warmblood horses before and during a euglycemic-hyperinsulinemic clamp

  2016cited by this paper
• Blood pressure response to catheter-based renal sympathetic denervation in severe resistant hypertension: data from the Greek Renal Denervation Registry

  2016cited by this paper
• The long road to leptin.

  2016cited by this paper
• Increased Feeding Speed Is Associated with Higher Subsequent Sympathetic Activity in Dogs

  2015cited by this paper
• Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms.

  2015cited by this paper
• Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial

  2015cited by this paper
• Glutamate receptors in the hypothalamic paraventricular nucleus contribute to insulin-induced sympathoexcitation.

  2015cited by this paper
• Phenotypic Characterization of Insulin-Resistant and Insulin-Sensitive Obesity.

  2015cited by this paper
• The sympathetic nervous system alterations in human hypertension.

  2015cited by this paper
• Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial

  2015cited by this paper
• Blood pressure in Warmblood horses before and after a euglycemic-hyperinsulinemic clamp

  2015cited by this paper
• The relationship of body mass and fat distribution with incident hypertension: observations from the Dallas Heart Study.

  2014cited by this paper
• Sex-specific relations between fasting insulin, insulin resistance and incident hypertension: 8.9 years follow-up in a Middle-Eastern population

  2014cited by this paper
• Mechanism of salt-sensitive hypertension: focus on adrenal and sympathetic nervous systems.

  2014cited by this paper
• The pathophysiology of hypertension in patients with obesity

  2014cited by this paper
• The brain melanocortin system, sympathetic control, and obesity hypertension.

  2014cited by this paper
• Catheter-based radiorefrequency renal denervation lowers blood pressure in obese hypertensive dogs.

  2014cited by this paper
• Obesity-Related Hypertension and the Role of Insulin and Leptin in High-Fat–Fed Rabbits

  2013cited by this paper
• Experimental hyperleptinemia acutely increases vasoconstrictory sympathetic nerve activity in healthy humans.

  2013cited by this paper
• 11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.

  2013cited by this paper
• Arcuate nucleus injection of an anti-insulin affibody prevents the sympathetic response to insulin.

  2013cited by this paper
• Hypertension: physiology and pathophysiology.

  2012cited by this paper
• Melanocortin Signalling and the Regulation of Blood Pressure in Human Obesity

  2011cited by this paper
• Fatty Kidney, Hypertension, and Chronic Kidney Disease: The Framingham Heart Study

  2011cited by this paper
• Control of Blood Pressure, Appetite, and Glucose by Leptin in Mice Lacking Leptin Receptors in Proopiomelanocortin Neurons

  2011cited by this paper
• Sympathetic Response to Insulin Is Mediated by Melanocortin 3/4 Receptors in the Hypothalamic Paraventricular Nucleus

  2011cited by this paper
• Insulin acts in the arcuate nucleus to increase lumbar sympathetic nerve activity and baroreflex function in rats

  2011cited by this paper
• Efficacy of Spironolactone Therapy in Patients With True Resistant Hypertension

  2010cited by this paper
• Sympathetic function in human carriers of melanocortin-4 receptor gene mutations.

  2010cited by this paper
• Glutamatergic Receptor Activation in the Rostral Ventrolateral Medulla Mediates the Sympathoexcitatory Response to Hyperinsulinemia

  2010cited by this paper
• Modulation of blood pressure by central melanocortinergic pathways.

  2010cited by this paper
• Renal Sinus Fat and Poor Blood Pressure Control in Middle-Aged and Elderly Individuals at Risk for Cardiovascular Events

  2010cited by this paper
• Obesity-induced Hypertension: Role of Sympathetic Nervous System, Leptin, and Melanocortins*

  2010cited by this paper
• The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology.

  2010cited by this paper
• A comprehensive definition for metabolic syndrome

  2009cited by this paper
• Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As

  2009cited by this paper
• Low-dose spironolactone, added to long-term ACE inhibitor therapy, reduces blood pressure and urinary albumin excretion in obese patients with hypertensive target organ damage.

  2009cited by this paper
• Modulation of blood pressure by central melanocortinergic pathways.

  2009cited by this paper
• Chronic central nervous system hyperinsulinemia and regulation of arterial pressure and food intake

  2006cited by this paper
• Melanocortin-4 Receptor–Deficient Mice Are Not Hypertensive or Salt-Sensitive Despite Obesity, Hyperinsulinemia, and Hyperleptinemia

  2005cited by this paper
• The metabolic syndrome.

  2005cited by this paper
• Global burden of hypertension: analysis of worldwide data.

  2005cited by this paper
• Role of Adrenergic Activity in Pressor Responses to Chronic Melanocortin Receptor Activation

  2004cited by this paper
• Control by insulin of sodium potassium and water excretion by the isolated dog kidney

  2004cited by this paper
• Obesity and hypertension: two epidemics or one?

  2004cited by this paper
• Role of Hypothalamic Melanocortin 3/4-Receptors in Mediating Chronic Cardiovascular, Renal, and Metabolic Actions of Leptin

  2004cited by this paper
• Is obesity a major cause of chronic kidney disease?

  2004cited by this paper
• Aldosterone Antagonism Attenuates Obesity-Induced Hypertension and Glomerular Hyperfiltration

  2004cited by this paper
• The metabolic syndrome.

  2003cited by this paper
• Role of Melanocortin-4 Receptors in Mediating Renal Sympathoactivation to Leptin and Insulin

  2003cited by this paper
• The kidney, hypertension, and obesity.

  2003cited by this paper
• Hypothalamic Melanocortin Receptors and Chronic Regulation of Arterial Pressure and Renal Function

  2003cited by this paper
• Chronic Cardiovascular and Renal Actions of Leptin: Role of Adrenergic Activity

  2002cited by this paper
• The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension

  2001cited by this paper
• Inhibition of NO Synthesis Enhances Chronic Cardiovascular and Renal Actions of Leptin

  2001cited by this paper
• Pathophysiological role of leptin in obesity-related hypertension.

  2000cited by this paper
• Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic.

  1999cited by this paper
• Cardiovascular regulation during insulin infusion into the carotid or vertebral artery in dogs.

  1999cited by this paper
• Leptin-induced increase in sympathetic nervous and cardiovascular tone is mediated by proopiomelanocortin (POMC) products.

  1999cited by this paper
• Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defe

  1999cited by this paper
• Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice.

  1999cited by this paper
• Failure of acute hyperinsulinemia to alter blood pressure is not due to baroreceptor feedback.

  1999cited by this paper
• Chronic leptin infusion increases arterial pressure.

  1998cited by this paper
• Insulin-induced hypertension in rats depends on an intact renin-angiotensin system.

  1997cited by this paper
• Sympathetic and cardiorenal actions of leptin.

  1997cited by this paper
• Relationship between muscle sympathetic nerve activity and plasma leptin concentration.

  1997cited by this paper
• Receptor-mediated regional sympathetic nerve activation by leptin.

  1997cited by this paper
• Intra‐abdominal pressure, sagittal abdominal diameter and obesity comorbidity

  1997cited by this paper
• Inhibition of thromboxane synthesis attenuates insulin hypertension in rats.

  1997cited by this paper
• Contrasting autonomic and hemodynamic effects of insulin in healthy elderly versus young subjects.

  1997cited by this paper
• Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance.

  1996cited by this paper
• Hypertension in obese Zucker rats. Role of angiotensin II and adrenergic activity.

  1996cited by this paper
• Chronic adrenergic receptor blockade does not prevent hyperinsulinemia-induced hypertension in rats.

  1996cited by this paper
• Hemodynamic and renal responses to chronic hyperinsulinemia in obese, insulin-resistant dogs.

  1995cited by this paper

• Lycopene's Role in Mitigating Obesity‐Induced Cardiac Remodeling: Insights Into Inflammatory and MMP‐2 Pathways

  2026cites this paper
• The triglyceride glucose-body mass index is positively associated with higher risk of hypertension in rural southwest Chinese population: a cross sectional study

  2026cites this paper
• Efficacy and safety of lower-carbohydrate dietary patterns for metabolic associated fatty liver disease: evidence from randomized controlled trials with grade analysis

  2026cites this paper
• How Emerging Digital Health Technologies Based on Dietary and Physical Activity Regulation Improve Metabolic Syndrome-Related Outcomes in Adolescents: A Systematic Review.

  2026cites this paper
• Combined effect of triglyceride-glucose index and glucose disposal rate on cardio-cerebrovascular disease

  2026cites this paper
• Bioactive Components in Milk with Antidiabetic Potential: From Molecular Mechanisms to Clinical Applications.

  2026cites this paper
• Association between modified cardiometabolic index and cardiometabolic multimorbidity in middle-aged and older adults: evidence from two nationwide cohort studies.

  2026cites this paper
• Prospective associations of triglyceride-glucose related indices with cardiovascular disease and mortality in individuals with metabolic syndrome: evidence from the UK biobank

  2026cites this paper
• Association between new metabolic indices and atrial fibrillation in elderly hypertensive patients in China.

  2026cites this paper
• Changes in estimated glucose disposal rate and incident heart disease: A prospective cohort study from CHARLS and ELSA

  2026cites this paper
• Cross-sectional association of the metabolic score for insulin resistance with hypertension in multi-ethnic patients with premature coronary artery disease: the IPAD study

  2026cites this paper
• Insulin Resistance Increases Stroke Risk: A Cross-sectional Study from NHANES 1999-2018 and A Mendelian Randomization Study.

  2026cites this paper
• Association Between the Triglyceride–Glucose Index and Incident Chronic Severe Pain in Middle‐Aged and Older Chinese Adults: A Nationwide Cohort Study

  2026cites this paper
• Influence of endogenous estrogen exposure on the development of hypertension in a cohort study using multistate model analysis

  2026cites this paper
• Insulin Resistance and Inflammation

  2026cites this paper
• Mechanisms linking hypertension to cardiovascular and cerebrovascular diseases and their clinical implications: A comprehensive review.

  2026cites this paper
• Dual clinical utility of cholesterol, high density lipoprotein, and glucose index: from advanced cardiovascular-kidney-metabolic syndrome pathogenesis to inflammatory-mediated mortality across early-transitional stages

  2025cites this paper
• Prevalence, Morbidity and Mortality of Diabetes Mellitus in 9009 Adult Patients over 12 Years in the Internal Medicine Department of the Bouaké University Hospital

  2025cites this paper
• First Trimester Triglyceride-Glucose Index and Lipid Profile as Predictive Factors in the Diagnosis of Late-Onset Preeclampsia: Can We Prevent It?

  2025cites this paper
• DOT1L promotes phenotypic transition of vascular smooth muscle cells following vascular injury in diabetes through activation of the FGFR4/PI3K/AKT/Jag/Notch signaling pathway.

  2025cites this paper
• Downregulated expression of hepatic β-Klotho is associated with the hypertensive phenotype in SHR

  2025cites this paper
• Mediating Role of Insulin Resistance in the Association Between Body Composition and Hypertension

  2025cites this paper
• The relationship between cholesterol, high-density lipoprotein, and glucose index and hypertension: A study based on two national cohorts

  2025cites this paper
• Association between the triglyceride-glucose index and the risk of left ventricular aneurysm formation among patients with acute ST-segment elevation myocardial infarction

  2025cites this paper
• Association of hemoglobin glycation index with frailty and all-cause mortality in hypertensive patients

  2025cites this paper
• Hepatic steatosis index as an independent predictor of hypertension in patients with type 2 diabetes: a cross-sectional study

  2025cites this paper
• Cumulative triglyceride-glucose index and hypertension risk: a longitudinal cohort study

  2025cites this paper
• Common Pathophysiological Mechanisms Connecting Dyslipidemia and Hyperuricemia: a Narrative Review.

  2025cites this paper
• Association between average triglyceride glucose-body mass index and risk of hypertension in middle-aged and elderly Chinese: A study based on Chinese CHARLS cohort data

  2025cites this paper
• EFFECTS OF SUPPLEMENTATION, DIET AND FASTING ON INSULIN RESISTANCE

  2025cites this paper
• Insulin Resistance at the Crossroads of Metabolic Inflammation, Cardiovascular Disease, Organ Failure and Cancer

  2025cites this paper
• Effects of omega-3 fatty acids (n-3 PUFAs) on cardiovascular and muscular health across various populations: a review of supplementation benefits

  2025cites this paper
• Skeletal Muscle and Cardiovascular Health.

  2025cites this paper
• Longitudinal changes in estimated glucose disposal rate and risk of cardiovascular disease among adults with cardiovascular–kidney–metabolic syndrome stages 0–3: a nationwide prospective cohort study

  2025cites this paper
• Sensory Circumventricular Organ Insulin Signaling in Cardiovascular and Metabolic Regulation

  2025cites this paper
• Association between the cardiometabolic index and all-cause and cardiovascular mortality in diabetes and prediabetes

  2025cites this paper
• Study of integral indices for diagnosing insulin resistance in horses Authors

  2025cites this paper
• Pathophysiology of Prediabetes Hyperinsulinemia and Insulin Resistance in the Cardiovascular System

  2025cites this paper
• Associations between dietary and lifestyle insulinemic indices and cardiometabolic risk factors in adults undergoing abdominal surgery

  2025cites this paper
• Associations of metabolic obesity phenotypes with cognitive aging in middle-aged and elderly Chinese adults.

  2025cites this paper
• A Novel Theoretical Hypothesis on Comorbidity in the Elderly—The Disease of Sympathetic Overdrive (DSO)

  2025cites this paper
• Cross-Lagged Relationship Between Adiposity and HOMA and Mediating Role of Adiposity Between Lifestyle Factors and HOMA Among in Mexican Health Workers

  2025cites this paper
• Further Insights into Ambulatory Blood Pressure Modulation by Age and Body Weight.

  2025cites this paper
• The ZJU index as a predictor of all-cause mortality in metabolic syndrome patients: A prospective cohort study from NHANES 2005–2018

  2025cites this paper
• The impact of hyperinsulinemia on short-term prognosis in patients with hypertriglyceridemia-induced acute pancreatitis

  2025cites this paper
• Atypical glucose response patterns in pregnant women and the association with hypertensive disorders of pregnancy: A retrospective analysis.

  2025cites this paper
• Dietary and lifestyle modifications for effective management of hypertension: A comprehensive review

  2025cites this paper
• In Vitro Chronic Hyperinsulinemia Induces Remodelling of Vascular Smooth Muscle Cells from Young Men and Women in a Sex Hormone Independent Manner

  2025cites this paper
• Risk of Insulin Resistance in 44,939 Spanish Healthcare Workers: Association with Sociodemographic Variables and Healthy Habits

  2025cites this paper
• Association Between Resting Heart Rate and the Risk of Incident Hypertension Among Older Chinese Adults: A Prospective Cohort Study

  2025cites this paper
• Association between the cumulative estimated glucose disposal rate and incident cardiovascular disease in individuals over the age of 50 years and without diabetes: data from two large cohorts in China and the United States

  2025cites this paper
• Association between estimated glucose disposal rate and prediction of cardiovascular disease risk among individuals with cardiovascular-kidney-metabolic syndrome stage 0–3: a nationwide prospective cohort study

  2025cites this paper
• An association between average daily sleep duration and gallstones in US adults

  2025cites this paper
• Effects of moderate-to-vigorous physical activity on the associations between an insulin resistance surrogate and incident cardiovascular disease and all-cause mortality: a UK Biobank cohort study

  2025cites this paper
• The triglyceride-glucose index and acute kidney injury risk in critically ill patients with coronary artery disease

  2025cites this paper
• Understanding the link between insulin resistance and cognition: a cross-sectional study conducted in an urban, South Indian cohort

  2025cites this paper
• Association of metabolic score for insulin resistance with incident metabolic syndrome: a cohort study in middle-aged and older adult Chinese population

  2025cites this paper
• Physiological and Metabolic Predictors of Adverse Outcomes One Year After Coronary Intervention: A Two-Tiered Approach.

  2025cites this paper
• The relation between body mass index and target organ damage and the mediating role of blood pressure

  2025cites this paper
• Association between TyG-BMI and early-onset hypertension: evidence from NHANES

  2025cites this paper
• Associations of triglyceride glucose-body mass index and the combination of sedentary behavior and physical activity with risks of all-cause mortality and myocardial infarction: a cohort study from the UK biobank

  2025cites this paper
• Comparative analysis of three BMI cutoffs for five metabolic abnormalities in the population of Western Guangdong, China

  2025cites this paper
• Prognostic value of triglyceride-glucose index on predicting major adverse cardiovascular events in hypertensive patients: a systematic review and meta-analysis

  2025cites this paper
• Metabolic Dysfunction-Associated Steatotic Liver Disease and Chronic Kidney Disease: Unraveling Connections and Advancing Therapies

  2025cites this paper
• Association Between Estimated Glucose Disposal Rate and Cardiovascular Disease Risk Across Different Sarcopenia Statuses: A Retrospective Cohort Study.

  2025cites this paper
• Risk of Insulin Resistance: Comparison of the Commerce vs. Industry Sector and Associated Variables

  2025cites this paper
• Triglyceride-glucose index: a novel predictor of major adverse cardiovascular events and cerebrovascular events in patients with acute ST-segment elevation myocardial infarction

  2025cites this paper
• Unraveling the Connection between PCOS and renal Complications: Current insights and Future Directions.

  2025cites this paper
• New insight on dietary strategies to increase insulin sensitivity and reduce diabetes prevalence: an expert perspective and recommendation

  2025cites this paper
• Ambulatory Blood Pressure Characteristics are Modulated by Age and Body Weight in Hypertensives: A Cohort Study of 35,367 Patients.

  2025cites this paper
• Hypertension and associated factors among patients with diabetes mellitus attending a follow-up clinic in central Ethiopia

  2025cites this paper
• Effects of dexamethasone-induced insulin resistance rat model on self-care behaviors and brain-derived growth factor.

  2025cites this paper
• The role of cardiovascular disease in the association between estimated glucose disposal rate and chronic kidney disease

  2025cites this paper
• Exploring the association between hemoglobin glycation index and cognitive function in older adults with hypertension: a cross-sectional study

  2025cites this paper
• Epiregulin dysregulation in polycystic ovary syndrome: metabolic and ovarian implications

  2025cites this paper
• The triglyceride-glucose index as a measure of insulin resistance, mediated the relationship between air pollution and hypertension in middle-aged and older adults.

  2025cites this paper
• Triglyceride-Glucose Index and Major Adverse Cardiovascular Events in Diabetic and Nondiabetic Patients: A Systematic Review and Meta-Analysis

  2025cites this paper
• Arterial Hypertension in Cardio-Renal-Metabolic Syndrome: New Targets and Proven Treatment Approaches.

  2025cites this paper
• Association between the triglyceride-glucose index and its combined obesity indicators and the risk of hypertension in middle-aged and older Chinese adults: A nationwide cross-sectional study

  2025cites this paper
• Insulin resistance and poorer treatment outcomes in depression: evidence from UK Biobank primary care data.

  2025cites this paper
• 心肾代谢综合征0-3期人群胰岛素抵抗替代指标与新发心血管疾病的关联：一项前瞻性队列研究

  2025cites this paper
• Triglyceride-glucose index and incidence of hypertension, a population-based observational study of the Japanese population.

  2025cites this paper
• Vitamin E intake mediates the associations of triglyceride-glucose index and its related parameters with phenotypic age acceleration in middle-aged and elderly population

  2025cites this paper
• BLOOD GLUCOSE ALTERATIONS AND ASSOCIATED RISK FACTORS IN RESIDENTS OF SOUTH MARANHÃO, BRAZIL

  2025cites this paper
• The Hidden Price of Plenty: Oxidative Stress and Calorie-Induced Cardiometabolic Dysfunction

  2025cites this paper
• Noninvasive On-Skin Biosensors for Monitoring Diabetes Mellitus

  2025cites this paper
• Assessment of the Association Between Cardiac Metabolic Markers and Carotid Atherosclerosis, and the Role of Insulin Resistance

  2025cites this paper
• Effect of Hypertension on Long-term Adverse Clinical Outcomes and Liver Fibrosis Progression in MASLD.

  2025cites this paper
• Metformin in polycystic ovary syndrome: unraveling multi-stage therapeutic mechanisms from puberty to long-term health outcomes

  2025cites this paper
• Prognostic relevance of the triglyceride–glucose index in patients after thrombectomy for acute anterior circulation occlusion

  2025cites this paper
• Prediction of Hypertension Risk in Patients with Fatty Liver Disease Using the Triglyceride-Glucose-Body Mass Index

  2025cites this paper
• Integrated network pharmacology and in vivo experimental approaches unveil the modulatory effect of telmisartan on autophagy in a rat model of nonalcoholic steatohepatitis.

  2025cites this paper
• Association of the triglyceride-glucose index combined with a body shape index with all-cause and cardiovascular mortality in individuals with cardiovascular-kidney-metabolic syndrome stage 0–3: findings from two prospective cohorts

  2025cites this paper
• Association of triglyceride-glucose index with risk of cardiovascular disease among patients with prediabetes: population based prospective cohort study

  2025cites this paper
• Retrospective and longitudinal study of blood pressure in school-aged children.

  2025cites this paper
• Cardiometabolic index as a predictor of gallstone incidence in U.S. adults: insights from NHANES 2017–2020

  2025cites this paper
• Inflammatory markers link triglyceride-glucose index and obesity indicators with adverse cardiovascular events in patients with hypertension: insights from three cohorts

  2025cites this paper
• Metabolic Status and Hypertension: The Impact of Insulin Resistance-Related Indices on Blood Pressure Regulation and Hypertension Risk.

  2025cites this paper
• Triglyceride glucose index–body mass index as a predictor of coronary artery disease severity in patients with H-type hypertension across different glucose metabolic states

  2025cites this paper
• Childhood triglyceride-glucose index and pre-hypertension in adulthood: a prospective cohort study

  2025cites this paper